Gastrin stimulates the function' and growth of the oxyntic mucosa of the rat2 as well as human.3 Initially, the positive trophic effect of gastrin was thought to be particularly noticeable on the acid producing parietal cell.2 It has been realised, however, that gastrin has a specific trophic effect on the enterochromaffin like cell,4 whereas the effect on the parietal cell seems to be parallel to the general trophic effect of gastrin on the oxyntic mucosa.5 The enterochromaffin like cell produces histamine in all vertebrates.6 Gastrin stimulates release from7 and synthesis8 of histamine in this cell in quantities that, at least in the rat, fully explain the acid stimulatory effect of gastrin.9
Abstract
To evaluate whether the general trophic effect of gastrin on the oxyntic mucosa is an indirect effect mediated by histamine H2 receptors, sustained 24 hour hypergastrinaemia was induced in Sprague-Dawley rats by treatment with the long acting and potent histamine H2 antagonist loxtidine for five months. The trophic effect was assessed by weight, enumeration of total mucosal cells, parietal cells, and enterochromaffin like cells in smears stained for the actual cells after enzymatic dispersion of the mucosa, and by biochemical analysis of oxyntic mucosal homogenates. The weight of the whole stomach and the oxyntic mucosa increased by 12-7% (p=0O016) and 27 .5% (p=0006), respectively. Total 16 rats received the vehicle (water) by gavage once daily for five months. The loxtidine dose was 100 mg/kg body weight, a dose similar to that previously shown to induce a sustained 24 hour hypergastrinaemia.19 Otherwise, the two groups were housed and fed similarly. After three months, blood samples were taken from a superficial vein for determination of plasma gastrin concentration 24 hours after the last dosing. At the end of the study period, the rats were anaesthetised with 0x2 ml/100 g body weight of a combination of (per ml) 2-5 mg fluanisone, 0 05 mg phentanyl, and 1 25 mg midazolam. The animals were allowed to eat freely until anaesthetised. The last dose of loxtidine was given two hours before the rats were killed. The rats were killed by exsanguination by heart puncture. The blood was collected in tubes containing EDTA and centrifuged. Plasma gastrin concentration was determined by radioimmunoassay.22
CELL DISPERSION AND COUNTING
The stomach was removed from seven rats in each group and transformed to an everted sack. The mucosal cells were dispersed by means of proteolytic enzymes (Pronase-E; Merck, Darmstadt, Germany) installed into the everted stomach and incubated at 37°C for 105 minutes, essentially as described by Lewin et From the remaining rats (eight rats in the loxtidine group and nine rats in the control group), the stomach was removed, opened along the greater curvature, rinsed in ice cold 09% saline, and weighed. After removal of the antrum, the oxyntic mucosa was scraped off the remaining body of the stomach, diluted in distilled water to 100 mg/ml and homogenised. The homogenates were stored at -70°C until analysis.
The histamine content of the oxyntic mucosa was determined by radioimmunoassay, as described previously (Immunotech, Marseilles, France).25 26 Enzymatic activity of mucosal histidine decarboxylase was determined by the procedure described by Beaven et 
Results
The Table summarises the results. Loxtidine induced a significant increase in plasma gastrin concentration two hours and 24 hours after the last dose. Loxtidine did not affect the weight of the rats. The weights of the whole stomach and oxyntic mucosa were significantly increased in the rats treated with loxtidine. The total amount of protein also increased, although of borderline statistical significance. On the other hand, the number of gastric mucosal cells did not increase significantly. The increase in parietal cell mass induced by loxtidine was more noticeable, but did not reach significance. The mucosal amount of the parietal cell specific enzyme H+,K+-ATPase was unaffected by the loxtidine treatment.
The enterochromaffin like cell mass was three times as high in the loxtidine treated rats with an even more noticeable increase in the activity of the enterochromaffin like cell specific enzyme histidine decarboxylase, and mucosal histamine content.
Discussion
In this study we have assessed the total masses of the parietal and enterochromaffin like cells by enzymatic dispersion and counting of the mucosal cells followed by differential counting on smears stained for the actual cells. This method is rapid, and permits determination of the total cell masses, not only the density of the different cell types. Furthermore, a new enzyme linked immunosorbent assay for the determination of H+,K+-ATPase in mucosal homogenates is described, and quantification of this specific enzyme is also used for assessment of the parietal cell mass. An immunoassay of pig and human gastric H+,K+-ATPase has been described previously, but that method could not be used on homogenates. 31 The findings confirm the specific trophic effect of profound acid inhibition on the enterochromaffin like cells,4 28 an effect mediated by hypergastrinaemia.4 32 The magnitude of the enterochromaffin like cell hyperplasia recorded in this study, is comparable with what has been found previously after prolonged hypergastrinaemia, assessed by histomorphomtery. 4 18 19 28 The histidine decarboxylase activity increased more than the enterochromaffin like cell mass, showing that loxtidine treatment increased the enzyme activity in the individual enterochromaffin like cells. Gastrin seems to regulate the histidine decarboxylase gene expression,33 and the increase in enzyme activity in the individual cells therefore probably reflects the hypergastrinaemia in the loxtidine treated rats.
The whole stomach weight increased in the loxtidine treated group, and this increase was mainly caused by an increased weight of the oxyntic mucosa. The oxyntic mucosal cell number and the total amount of mucosal protein increased only slightly and nonsignificantly. Taken together, these findings suggest that the increase in the oxyntic mucosal weight may partly be caused by an increase in the intercellular matrix. The parietal cell mass showed a stronger tendency to increase than the total mucosal cell mass, and in percentage terms the increase in parietal cells reached significance. Accordingly, the general trophic effect of gastrin on the oxyntic mucosa seems not to be mediated by the histamine H2 receptor. This is in agreement with a recent study by Andersson et a134 showing that hypergastrinaemia induced a general trophic effect on the oxyntic mucosa also when the enterochromaffin like cells were totally depleted of histamine.
Initially, gastrin was thought to have a specific trophic effect on the parietal cell,2 but this has been difficult to confirm.5 35 36 In this study, the number of parietal cells increased by 24 In conclusion, we describe a new and simplified method for the determination of different mucosal cell masses, and confirm that hypergastrinaemia secondary to longterm acid inhibition induced by a histamine H2 blocker evokes a specific trophic effect of the enterochromaffin like cell and a less pronounced general trophic effect of the oxyntic mucosa. Accordingly, it is highly unlikely that the general trophic effect of gastrin on the oxyntic mucosa is mediated by a histamine H2 receptor. The enterochromaffin like cell, however, having ultrastructural features of a peptide producing cell,39 may also secrete peptides with trophic effect on the gastric progenitor cells.
